Not all hair loss is created equal, and the distinction matters more than most patients realize. At De Haar Hair Restoration, one of the most important questions we answer during a Trichoscopy consultation is deceptively simple: is this hair loss scarring, or non-scarring? The answer shapes everything that follows, including whether a hair transplant is likely to succeed.

The Core Difference

Hair follicles are living structures. In non-scarring alopecia, the category that includes androgenic (pattern) hair loss, the most common cause of thinning in both men and women, the follicle itself survives, even as it shrinks and produces thinner, shorter hairs over time. Because the follicle is still intact beneath the surface, it generally remains capable of producing hair again, and it’s this category of hair loss that responds well to FUE transplantation.

In scarring (cicatricial) alopecia, the follicle itself is destroyed and replaced with fibrous scar tissue. Once that happens, the follicle cannot regenerate hair on its own, and the scalp in the affected area typically appears smooth, shiny, and free of the small pore-like openings (follicular ostia) where hair would normally emerge. This distinction is the reason a thorough diagnostic workup, not just a visual scan, is essential before any treatment plan is proposed.

Common and Rare Forms of Scarring Alopecia

Several conditions fall under the scarring alopecia umbrella, and they can look similar to one another on the surface, which is why proper diagnosis matters:

• Lichen planopilaris (LPP) is an inflammatory condition that often causes redness, scaling, and itching around affected follicles before scarring sets in.
• Discoid lupus erythematosus (DLE) is an autoimmune condition that can cause scarring patches on the scalp, sometimes alongside skin changes elsewhere on the body.
• Central centrifugal cicatricial alopecia (CCCA) is a slowly progressive scarring pattern that typically begins at the crown.
• Folliculitis decalvans is driven by chronic follicular infection and inflammation.
• Pseudopelade of Brocq is a rare, quiet form of scarring alopecia that often shows little to no visible inflammation, sometimes representing the end stage of one of the conditions above once active inflammation has resolved.

Why this matters for Transplant Candidacy

A hair transplant relocates healthy, living follicles from a donor area to an area of thinning, but it cannot revive a follicle that has already been replaced by scar tissue, and it cannot stop an underlying disease process that is still active. This is why, at De Haar, candidacy always starts with two questions:

• Is the underlying condition currently active, or has it been stable and quiet for a meaningful period of time?
• Is the follicle itself still present, or has it been permanently replaced by scar tissue?

If a scarring condition is still active, transplantation is generally not recommended until it has been medically managed and confirmed stable, since new grafts placed into inflamed tissue are unlikely to survive. Once a scarring alopecia has been confirmed inactive, transplantation can sometimes be considered, though outcomes are typically less predictable than with non-scarring hair loss, since graft survival in scarred tissue tends to be more variable.

How Do We Diagnose It

Every potential hair transplant patient at De Haar begins with Trichoscopy, a magnified scalp examination that lets our team look closely at individual follicles, the surrounding skin, and any signs of inflammation, scaling, or scarring. In cases where a scarring process is suspected, we work alongside dermatology to arrange further evaluation, in some rare a scalp biopsy may be recommended before any surgical plan is discussed. This diagnosis-first approach protects patients from pursuing a procedure that isn’t right for their type of hair loss, and it ensures that if an active inflammatory condition is present, it gets treated on the right timeline.

The Bottom Line

If you’ve noticed smooth, shiny patches of hair loss, or hair loss accompanied by redness, itching, or scaling, it’s worth having it evaluated before assuming a transplant is the answer. The good news is that an accurate diagnosis, whether it points toward pattern hair loss or a scarring condition that needs to be addressed first, gives you a clear and honest path forward. At De Haar, once you’re a patient, we work diligently on your behalf to discover the cause, diagnose the condition, manage and stabilize remaining and surrounding follicles and treat the cause of your hair loss before recommending any procedure. Once stabilized for a period of time, you may be a candidate for transplantation. Come talk to us today and discover the possibilities best suited to you to protect and restore your hair.

read more about hair loss diagnosis here.

 

 

Telogen effluvium is one of the most common causes of sudden, diffuse hair loss and shedding. It is a temporary disruption of the normal hair growth cycle. Under normal conditions about 85 to 90% of scalp hairs are in the anagen phase, the growth phase of the hair. Around 10 to 15% are in the telogen phase which is the resting and shedding phase of the hair cycle.

What causes telogen effluvium?

 In telogen effluvium, a stressful trigger disrupts the hair cycle and causes a larger than normal number of hairs to shift prematurely into the telogen phase. These hairs are then shed several months later, often all at once.

When does telogen effluvium occur?

One of the most confusing aspects of telogen effluvium is the delayed onset. The triggering event occurs first then the hair follicles enter the telogen phase and shedding begins 2 to 4 months later. This delay often makes it difficult for patients to connect their hair loss to the original cause.

What are the common causes of telogen effluvium?

Common triggers of telogen effluvium are often psychological or emotional stress. These triggers can include:

• acute illness
• chemotherapy
• high fevers
• surgery or hospitalizations
• rapid weight loss
• crash dieting
• sudden hormonal changes and thyroid imbalance
• severe emotional stress
• nutritional deficiencies in Iron, protein, or zinc
• medications

How does telogen effluvium present itself?

Telogen effluvium typically presents as diffuse hair shedding across the entire scalp, and one may notice an increase in the falling out of the hair while washing and brushing the hair or on pillows. Often a thinning ponytail and reduced overall hair density is noticed. In general, there is a normal looking scalp with no scarring or inflammation. Importantly the frontal hairline is generally preserved which sometimes helps distinguish telogen effluvium from other forms of hair loss.

Is telogen effluvium triggered hair loss permanent?

Telogen effluvium hair loss in most cases is not permanent. It is generally reversible once the underlying trigger is addressed but it sometimes can become chronic if the causes are not dealt with.

When will my hair grow back?

Hair regrowth typically begins within 3 to 6 months, though full density may take 9 to 12 months to return, however telogen effluvium can sometimes become chronic if the trigger persists.

How do I know if my hair loss is genetic or caused by a trigger?

Unmasking underlying androgenetic alopecia especially in genetically predisposed individuals is important and this is why proper diagnosis by a hair loss specialist is essential. read the science behind hair loss 

How can I tell the difference?

It is important that the difference between hair loss in androgenetic alopecia and telogen effluvium be identified. The key distinctions of telogen effluvium is that it has a sudden onset, being trigger-based and the excessive shedding is often reversible whereas in diffuse hair loss caused by androgenetic alopecia, there is a gradual progression of hair loss that is influenced by genetics and hormones along with miniaturization of the hair follicles requiring long term management. A hair loss specialist may take a thorough medical history, do a scalp examination and sometimes Trichoscopy or bloodwork to distinguish the difference. read hair loss diagnosis 

Is there a cure for telogen effluvium?

There is no single medication that cures telogen effluvium, but management focuses on identifying and correcting the triggers that caused it such as addressing Iron, and vitamin or nutritional deficiencies if present, managing stress and sleep and instituting gentle hair care practices. In some cases, topical minoxidil and other treatments may be recommended to support regrowth, particularly if shedding masks an underlying patterned hair loss.

Avoiding unnecessary panic

Although telogen effluvium can be emotionally distressing it is one of the most treatable causes of hair loss. Education, reassurance and proper evaluation are often the most important aspects of care. Early recognition helps prevent unnecessary panic, inappropriate treatments and delayed diagnosis of other conditions.

If you are experiencing sudden or excessive hair shedding, a professional evaluation and diagnosis to determine the cause will allow you to start treatment early and stop the loss no matter the cause.

Cost is almost always the first question people ask when they begin researching hair restoration. It’s a fair question and one that deserves a straight, transparent answer. The short version: hair transplant costs vary widely, typically ranging from $3,500 to $12,000 or more. But that range alone tells you very little. Understanding why prices differ so significantly is what empowers you to make a smart, informed decision one that protects both your investment and your health. At De Haar Hair Restoration our cost per graft is $3.50 to $6 CDN per graft making it one of the most affordable transplants for both Canadians and US citizens  ( a bonus particularly for Americans considering the exchange rate on the US dollar,)

Why Is There Such a Wide Price Range?

Hair transplant pricing is not one-size-fits-all. Several key factors influence the final cost of your procedure.

1. Number of Grafts Required

The most significant cost driver is how many hair grafts you need. Pricing is often quoted on a per-graft basis, typically ranging from $3.50 to $8  per graft depending on the clinic and technique. A patient requiring 1,500 grafts will pay considerably less than one requiring 4,000. It is also important to note that each hair follicle produces anywhere from 1 to 4 hairs so you are not paying per hair but per graft. Curly coarse hair creates the illusion of more density so the type of donor hair plays a role in what one needs for appropriate coverage. The number of grafts needed is determined by the extent of your hair loss, your desired density, quality and type of donor hair, procedure method and factors your surgeon will derive from your assessment during your consultation.

2. Technique: FUE vs. FUT

Follicular Unit Extraction (FUE) is generally a bit more expensive than Follicular Unit Transplantation (FUT) because it is more time-intensive. FUE requires individual follicle extraction, which demands greater surgical precision and a longer procedure time.

3. Surgeon Experience and Reputation

A highly experienced, board-certified hair restoration surgeon will often command a higher fee and for good reason. Their skill directly influences the naturalness of your results, graft survival rates, and the safety of your procedure.

4. Geographic Location

Clinic location plays a meaningful role in pricing. Practices in major metropolitan areas or high cost-of-living regions typically charge more than those in smaller markets. This is also why international “hair transplant tourism” has grown  though it comes with its own set of risks.

5. Clinic Facilities and Technology

State-of-the-art facilities, advanced instrumentation, and experienced surgical support teams all contribute to overhead costs that are reflected in pricing. These are investments in your safety and the quality of your outcome. One of the advantages of having your hair transplant in Canada is the extremely strong regulatory oversight over physicians, surgeons and patients safety standards. This oversight helps ensure the clinics meet established standards for Quality, infection prevention and professional accountability giving patients confidence in their care.

6. Aftercare and Follow-Up

At De Haar we include comprehensive post-operative care, follow-up appointments, and ongoing support as part of our service. Clinics that offer unusually low prices and too good to be true deals often cut corners, may have hidden fees and often leave patients without guidance and support during the critical healing period.

What May Not Included in the Quoted Price at other facilities?

Before committing to any procedure, ask your clinic exactly what is and is not covered. Common additional costs in some clinics may include:

• Pre-operative consultations and assessments
• Medications (pain relief, antibiotics, post-op treatments)
• PRP (Platelet-Rich Plasma) therapy, if recommended
• Follow-up visits beyond a standard number
• Touch-up procedures, if required

A transparent and ethical clinic will outline everything that is included clearly upfront so there are no surprises..

Is a Hair Transplant Covered by Insurance?

In most cases, no. Hair transplantation is classified as an elective cosmetic procedure and is therefore not covered by standard health insurance plans. Some exceptions may apply if hair loss is the direct result of injury, burns, or certain medical conditions but this is uncommon. It is worth verifying with your insurance provider.

Many reputable clinics offer financing options to make the procedure more accessible. If this is a consideration for you, ask about payment plans during your consultation.

The Real Cost of Going Cheap

It is important to address this directly: an unusually low price is rarely a good sign in hair restoration.

Clinics that drastically underprice their services often compensate by using less experienced surgical staff, rushing procedures, reducing graft quality, or cutting corners on hygiene and aftercare. The consequences poor graft survival, unnatural results, scarring, or infection can be both physically and emotionally costly to correct. Revision surgery to repair a poorly performed hair transplant is significantly more complex and expensive than doing it right the first time. When evaluating cost, always weigh it against the full picture: the surgeon’s credentials, the clinic’s track record, before-and-after results, and patient reviews.

What Does Good Value Actually Look Like?

A well-priced hair transplant from a qualified clinic should include:

• A thorough pre-operative consultation and candidacy assessment
• A clearly outlined surgical plan tailored to your specific hair loss pattern
• A procedure performed  by a licensed, experienced surgeon and team
• Transparent graft count and technique documentation
• Comprehensive aftercare instructions and follow-up support
• Realistic expectations communicated clearly before you commit

The Bottom Line

A  hair transplant is a long-term investment in your appearance and confidence. While cost is a legitimate consideration, it should never be the deciding factor on its own. The most important question is “What am I getting for what I pay?” Choosing a highly qualified surgeon with a proven track record, is consistently the decision patients are most satisfied with in the long run. De Haar Hair Restoration is able to offer world class hair transplant surgery with excellent free post transplant care included at affordable cost because our state of the art clinic is solely dedicated to hair restoration and that is all we do. Our pricing is transparent with no surprises. At De Haar Hair Restoration our cost per graft is $3.50 to $6 CDN per graft making it one of the most affordable transplants for both Canadians and US citizens  ( US citizens get extremely good value when you consider the exchange rate on the US dollar,) Eliminating the need and uncertainty of flying to Turkey for a Hair Transplant with no aftercare or oversight.

Have questions about pricing for your specific case? Book a consultation with Dr Gerbrands for a personalized assessment.

When people think about hair restoration, they often think immediately about a hair transplant with surgery. Surgery is only one part of modern hair restoration. For many men and women experiencing thinning, shedding, or early hair loss, non-surgical hair restoration treatment may be the first or sometimes the only treatment needed. At De Haar Hair Restoration non-surgical treatment begins with something that is easily overlooked. Determining why the hair is being lost in the first place.

Hair loss is a symptom, not a single diagnosis. Genetics, hormones, nutritional deficiencies, medications, autoimmune disease, inflammatory scalp conditions, illnesses, stress and other medical factors can all contribute to changes in the hair. That means a  treatment that is appropriate for one patient may be completely wrong for another. Once the underlying cause and condition of the follicles are understood, a personalized treatment plan can be developed. Depending on the diagnosis, this may include medication, regenerative therapies, microneedling, PRP, low level light therapy, or other non-surgical approaches.

Medical Treatment for Hair Loss

Some of the most effective non-surgical approaches to hair loss are medications. For androgenetic alopecia, better known as male or female pattern hair loss, medications may be used to slow progressive loss, preserving existing follicles and in many patients, improve the quality of miniaturized hair. Options may include minoxidil, finasteride, dutasteride, or other prescription therapies depending upon the patient’s diagnosis, gender, medical history, and individual circumstances. Medication can be particularly important because hair transplantation does not stop the progression of hair loss in the surrounding non transplanted area. For some patients, stabilizing the existing hair is therefore an important part of a long term restoration plan, even if they eventually choose to have a transplant.

PRP : Using Your Own Platelets to Support Hair Follicles

Platelet Rich Plasma, or PRP, is one of the regenerative treatments available at De Haar.  PRP begins with a small amount of the patient’s own blood. The blood is processed to concentrate the platelets within the plasma. These platelets contain growth factors and signaling proteins involved in tissue repair and cellular communication. The concentrated plasma is then delivered to the areas of thinning. The objective is to support hair follicles that are still alive but have become weakened or miniaturized. PRP does not manufacture new follicles in the area where they no longer exist. This distinction is very important. Someone with early to moderate thinning may have thousands of follicles that are still present but producing increasingly fine hairs or have ceased to produce hair yet they are still viable. Supporting these existing follicles is very different from attempting to restore a smooth, longstanding bald area. At De Haar Hair Restoration,  PRP may be used independently or incorporated into a broader treatment plan involving other therapies.

Microneedling and Regenerative Treatments

Microneedling is another non-surgical approach available at De Haar. The treatment uses very fine needles to create controlled microscopic channels in the scalp. This stimulates the body’s natural wound healing response and activates biological signaling involved in tissue repair. Microneedling can also be combined with selective, regenerative biological products. Depending upon the patient’s treatment plan microneedling may be used in conjunction with other therapies such as PRP, exosomes, peptides, or other biologic preparations. The objective is not simply to place a product on the scale. Microneedling creates controlled micro-injury while allowing treatment to reach the scalp more directly. For patients with miniaturized but viable follicles, this can form part of a broader strategy designed to support follicular health. Microneedling can also be used post-transplant to support the new growth and stimulate the follicles surrounding the transplanted follicles.

Low Level Light Therapy

Low level light therapy or LLLT is another option that may be incorporated into non-surgical hair restoration. LLLT uses specific wavelengths of light to interact with cells within the scalp. The treatment is intended to support cellular activity and follicular function without surgery or injections. Because it is noninvasive, light therapy can also be incorporated into a broader treatment program rather than being used alone. De Haar Hair Restoration also includes low level light therapy as part of its post-transplant care in appropriate patients.

Scalp Micropigmentation

Not every surgical treatment needs to stimulate hair growth. Sometimes the objective is to improve the visual appearance of density. Scalp micropigmentation, or SMP, uses specialized pigment. placed within the scalp to reduce the visual contrast between the hair and exposed scalp. For someone with thinning hair, this can make the scalp less noticeable and give the appearance of greater density. SMP can also be used in areas without the hair to create the appearance of closely shaped follicles. It can be particularly useful for selected patients who are not transplant candidates but prefer a non-surgical cosmetic solution to have the appearance of more density.

Diagnosing Hair Loss

Sometimes the hair is telling us that something else is happening. Excessive shedding can occur with thyroid abnormalities, nutritional deficiencies, hormonal changes, illness, medications, significant stress and systemic conditions. Hair loss can also result from autoimmune and inflammatory scalp diseases. Some forms of scarring alopecia can permanently damage the follicles if the underlying disease is not recognized and treated. In these situations, simply applying a hair growth product without identifying the underlying condition may delay appropriate treatment risking loss of viable follicles. This is why diagnosis is such an important part of the De Haar approach. Doctor Bea Gerbrands specializes in diagnosing and treating both common and rare forms of hair loss and scalp diseases. A comprehensive evaluation can include trichoscopy,  examination of the scalp and follicles, assessment of the pattern of loss and when appropriate, further medical investigation.

Can Non-Surgical Treatments Prevent a Hair Transplant?

A patient experiencing early hair loss may be able to preserve and improve enough existing hair that transplantation may become unnecessary or in certain cases can be postponed. For another patient, non-surgical treatment may help stabilize progressive loss before surgery. For someone with significant permanent follicular loss, non-surgical therapy may not provide enough restoration by itself. In such cases transplantation may then be the more appropriate way to replace the hair in areas where viable follicles are no longer present. There is also another possibility, which is combining the two approaches. A hair transplant can restore follicles to areas where there have been permanently lost, while medical or regenerative treatments may be used to support the patients remaining native hair surrounding the transplant. Modern hair restoration does not always have to be an either or decision.

Which Non-surgical Hair Restoration Treatment is Right for You?

There is no single non-surgical treatment that is best for everyone. The right treatment depends upon the cause of the hair loss, whether the follicles remain viable, how advanced the hair loss has become, and what the patients goals are. At De Haar, non-surgical options may include medical therapy, low level light therapy, microneedling with regenerative biologic products, in-office treatments. Steroidal injections, scalp micropigmentation, and individualized combination therapies. For some patients the goal is to reduce shedding, and for others it is to strengthen miniaturized hair. Some want to preserve as much existing hair as possible before considering surgery or other treatments, and others simply want to understand what is happening with their hair. This is why the first step is not choosing a treatment from a menu; it is getting the diagnosis right. At De Haar Hair Restoration, Dr. Bea Gerbrands evaluates the hair, scalp, and pattern of loss before developing an individualized treatment strategy. Surgery may be part of that plan, but increasingly there are many things we can do for hair loss without surgery at all. If you are experiencing hair loss it is important to understand the cause so that appropriate treatment can be initiated early if necessary. In certain circumstances such as with scarring alopecias early intervention is extremely important to help prevent permanent loss of the follicles.

read more about PRP Therapy

Hair transplantation is a very popular solution for those experiencing alopecia. There are many advantages to having a hair transplant over taking medication to maintain your hair. First of all, medication works to maintain the hair as much as possible, so long as you take the medication. For some people this is not an option due to potential side effects and although these side effects are rare, they do affect some people. Medications have helped hair transplant recipients to maintain any original hair that was already in the balding areas prior to adding the transplanted hair.  Hair transplants relocate viable, healthy hair producing follicles that are resistant to hair loss into areas that have already lost hair or areas where one may not have  any viable hair follicles to ever produce hair. Once hair is transplanted from the donor area,  these hairs continue to grow naturally, providing a permanent long-term solution.

Modern hair transplant techniques allow for a natural seamless look that is virtually undetectable. Transplanted hair is no different than any other natural hair on your head and after the brief healing period of the procedure itself, it can be treated just like any other hair on your scalp. There is absolutely no need for any special maintenance or products in order to keep your transplanted hair.

It is common knowledge that restoring your hair can significantly increase your confidence, boost your self esteem and give you a more attractive and youthful look. The best part is that people look so much more youthful and refreshed and with todays methods, they are so natural that they are virtually undetectable.

Transplants are more affordable than ever before, and in reality, they are far more economical in the long run compared to the expense of prescription medications and topical solutions that need to be taken daily for the rest of your life in order to maintain your hair. De Haar Hair Restoration combines world-class hair transplant expertise with competitive pricing, allowing you to receive outstanding care close to home without compromising on quality or after care and eliminates the uncertainty of travelling abroad.

The great thing about hair transplants is that you can actually design the hairline and create a custom look that suits your facial structure, and you can also obtain the desired density so long as you have the appropriate donor hair available. Hair transplants complement your appearance. The benefit of transplanted hair is that it is resistant to the effects of DHT, which is the hormone responsible for alopecia. Transplanted hair follicles continue to produce hair throughout your lifetime so, you never lose your investment. Feeling more confident in professional and social settings is a great benefit for those of us that worry about judgment from others or even  our own dissatisfaction in how we look.

Modern techniques of hair transplants are minimally invasive and have a very quick recovery time. In the hands of a qualified board-certified hair loss surgeon, there is minimal risk of complications and apart from an initial pinch that barely lasts a second or two at the start of the procedure when the scalp is anesthetized, it is a very comfortable procedure. Patients are minimally sedated so the time flies and by the time the transplant is finished it seems like you’ve only been sitting for a very short amount of time. During the procedure our patients listen to music, play games on their devices, chat  with staff and some even sleep. That’s how comfortable it is.

The benefits of a hair transplant will last a lifetime and it only takes one day to change everything. Of patients who choose hair transplantation, they often tell us they wish they had done it sooner and that it was so much easier than they had anticipated. Give us a call for hair that lasts a lifetime and start living your best life.

Hair thinning does not always mean that a follicle is gone. In many people with pattern hair loss, follicles remain alive but gradually become smaller and less productive. Each growth cycle may produce a finer, shorter hair until the follicle becomes nearly inactive. Platelet-rich plasma, commonly called PRP, is a nonsurgical treatment designed to support these weakened but still living follicles. It uses a concentrated portion of the patient’s own blood to deliver platelets and their signaling proteins directly to areas of thinning. Here is a closer look at the science, the growth factors involved, and the patients most likely to benefit.

What Is Platelet-Rich Plasma?

Blood contains several components, red blood cells, which carry oxygen, white blood cells, which participate in immune defense, plasma, the liquid portion of blood and among other things platelets, which help control bleeding and coordinate tissue repair. Platelets are best known for Their blood clotting potential, after an injury, but their role extends well beyond clotting. They contain small storage structures called alpha granules. When platelets become activated, these granules release growth factors, cytokines, and other signaling proteins involved in healing, blood-vessel formation, and importantly cell communication. During a PRP treatment, a small amount of the patient’s blood is drawn and placed into a centrifuge. Spinning separates the blood into layers, allowing the platelet-rich portion of the plasma to be collected. This concentrated plasma is then carefully injected into targeted areas of the scalp. Because PRP is prepared from the patient’s own blood, it is considered an autologous treatment. It does not introduce donor tissue or synthetic growth factors.

The Role of Alpha Granules in PRP

Much of PRP’s biological activity comes from specialized structures inside platelets called alpha granules. These tiny storage compartments contain a concentrated collection of growth factors and signaling proteins. When platelets become activated, the alpha granules release their contents into the surrounding tissue a process known as degranulation. Among the signaling molecules released are platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF), transforming growth factor-beta (TGF-β), and insulin-like growth factor (IGF). Together, these signals participate in cellular communication, tissue repair, blood-vessel formation, and other processes involved in the environment surrounding the hair follicle. In PRP hair restoration, the goal is to harness this naturally occurring platelet signaling to help support viable, miniaturized follicles and a healthier environment for hair growth.

How Are Platelets Activated?

For the growth factors stored within platelet alpha granules to become available, the platelets must first be activated. Activation occurs when platelets encounter signals associated with tissue injury and the clotting process, particularly substances such as collagen and thrombin. These signals bind to receptors on the platelet surface and trigger a rapid series of internal changes, including an increase in intracellular calcium. The platelet changes shape and its alpha granules move toward and fuse with the platelet membrane, releasing their stored growth factors and signaling proteins into the surrounding tissue through degranulation. In PRP treatment, activation can therefore occur naturally after PRP is introduced into the scalp and platelets encounter tissue-derived activating signals. Some PRP preparation systems may also use an external activator before application. Once released, these signaling molecules can interact with nearby cells and participate in the biological processes involved in tissue repair, vascular signaling, and the environment surrounding the hair follicle.

Why Do Hair Follicles Become Weaker?

A healthy follicle repeatedly moves through a growth cycle, This involves. The (anagen) growth phase, the (Catagen) transitioning phase, the (telogen) or resting phase and the (exogen)  phase where the hair is shed.  In androgenetic alopecia, the medical term for male and female pattern hair loss genetic and hormonal signals gradually shortens the anagen phase. Susceptible follicles undergo a process called miniaturization. With each hair growth cycle the follicle becomes smaller and produces hairs that are progressively thinner, shorter, and less visible. The follicle may still be present, but it is no longer functioning at its previous capacity. This distinction is important: PRP is intended to support viable follicles. It cannot reliably recreate follicles that have been permanently destroyed or replaced by scar tissue. That is one reason early treatment offers a better opportunity for improvement rather than waiting until an area has been completely bald for many years.

How PRP Growth Factors Affect the Follicle

PRP does not work through a single ingredient or pathway. It delivers a mixture of biological signaling factors that influence the follicle’s surrounding environment, including dermal papilla cells, follicular stem-cell regions, connective tissue, and nearby blood vessels. Among the growth factors commonly associated with PRP are the following:

Platelet-Derived Growth Factor

Platelet-derived growth factor, or PDGF, participates in cell growth, cell migration, blood-vessel development, and tissue remodeling. Around the follicle, it may help create an environment that supports repair and continued cellular activity.

Vascular Endothelial Growth Factor

Vascular endothelial growth factor, or VEGF, promotes angiogenesis and the development of new blood vessels from existing vessels. Hair follicles have substantial metabolic needs during active growth. A healthy network of tiny blood vessels around the follicle helps deliver oxygen and nutrients. VEGF activity may therefore support the vascular environment required by growing follicles.

Insulin-Like Growth Factor 1

Insulin-like growth factor 1, or IGF-1, is involved in cellular growth and survival. Within the hair follicle, it is associated with the proliferation of keratinocytes which are the cells that help form the hair shaft and with maintenance of the anagen phase.

Fibroblast Growth Factors

Fibroblast growth factors, including FGF-2 and FGF-7, participate in cell proliferation and communication between different follicular structures. Research suggests that these signals may support dermal papilla activity and encourage conditions associated with active hair growth.

Epidermal Growth Factor

Epidermal growth factor, or EGF, contributes to the growth and repair of epithelial tissue. Its effects depend on concentration, timing, and the surrounding biological environment, illustrating why PRP should be understood as a coordinated mixture of signals rather than a single “miracle” growth factor.

Transforming Growth Factor Beta

Transforming growth factor beta, or TGF-β, helps regulate inflammation, tissue remodeling, and communication between cells. Its biological effects are complex and can vary depending on the specific form, concentration, and stage of the hair cycle.

Together, these and other signaling molecules may affect several processes relevant to weakened follicles.

How PRP Supports Hair Growth

Supporting follicular cell survival. Pattern hair loss is associated with progressive follicular miniaturization and changes in the survival of important cells within the follicle. Laboratory research suggests that PRP can activate pathways such as Akt and ERK and increase anti-apoptotic signaling. Apoptosis is a controlled process through which cells shut down and are removed. Reducing premature apoptosis may help dermal papilla cells remain active for longer.

Encouraging the growth phase. PRP appears to influence signals involved in moving follicles toward anagen and maintaining them in that phase. A longer, healthier anagen phase gives the follicle more time to produce a stronger hair shaft. This does not mean that every dormant follicle can be permanently restarted. Rather, PRP may help viable but underperforming follicles function more effectively.

Improving the follicle’s vascular environment. By promoting angiogenic signaling, particularly through VEGF, PRP may improve the network of small blood vessels surrounding treated follicles. This can help support the nutritional and metabolic demands of active hair production.

Stimulating communication and tissue remodeling. Hair growth depends on ongoing communication among dermal papilla cells, epithelial cells, stem-cell regions, blood vessels, and surrounding tissue. PRP’s signaling proteins may help coordinate cell proliferation, migration, and remodeling within this microenvironment.

Why PRP Can Help a Miniaturized Follicle but Not Replace a Lost One

It is helpful to think of PRP as biological support for existing follicles, not as a method of creating brand-new follicles. A miniaturized follicle may still contain the structures needed to produce hair. If treatment improves its growth signals and surrounding environment, it may begin producing a thicker or more visible strand. This can lead to improvements in hair density, shaft caliber, or shedding. If a follicle has been permanently destroyed as can occur in advanced baldness or scarring alopecia, then growth-factor signaling alone cannot rebuild it. In those situations, hair transplantation or another treatment strategy may be more appropriate. A professional hair-loss evaluation is therefore essential. The diagnosis, duration of hair loss, degree of miniaturization, scalp health, and number of remaining follicles all affect the likelihood of improvement.

Who May Benefit From PRP?

The strongest clinical evidence for PRP involves androgenetic alopecia, including male pattern hair loss and female pattern hair loss. Systematic reviews have generally found that PRP can improve hair density in some patients, although results vary because preparation methods and treatment protocols are not yet standardized.  Patients with early-to-moderate thinning and visible miniaturized hair are generally more promising candidates than patients with smooth, long-standing bald areas. It is particularly helpful to many women who have diffuse hair loss and thinning throughout the scalp.

Patients seeking an additional nonsurgical option

PRP may be considered by people who cannot use certain medications, prefer a treatment made from their own blood, or want to add another modality to an existing hair-restoration plan. Depending on the diagnosis, PRP may be recommended alongside treatments such as minoxidil or prescription medication.

Hair-transplant patients

PRP may be incorporated into a hair-transplant plan to support healing and the health of existing or transplanted follicles. It should be viewed as a supportive treatment rather than a substitute for transplantation when follicular coverage is no longer adequate and follicles are no longer viable.

Selected patients with alopecia areata

Alopecia areata is an autoimmune condition and is biologically different from pattern hair loss. Studies of PRP for localized alopecia areata have reported encouraging results, but the evidence is less established and treatment must be individualized. PRP does not correct the underlying autoimmune process. Patients with alopecia areata should receive an accurate diagnosis and discuss all appropriate medical treatments with a qualified clinician.

Selected patients with chronic shedding

PRP has also been studied for chronic telogen effluvium, but evidence remains limited. Because shedding can result from iron deficiency, thyroid disease, illness, medication, hormonal changes, nutritional problems, or severe stress, the underlying trigger must be investigated and addressed.

Who May Not Be a Good Candidate?

PRP may be less suitable when The treatment area has been bald for many years, Follicles have been destroyed by significant scarring, the hair loss is  being driven by an untreated medical condition, where there is active scalp infection or inflammatory disease, the patient has a serious platelet bleeding or clotting disorder and if platelet counts are very low. Medication use and medical history should always be reviewed before treatment. Patients should not stop blood thinners, anti-inflammatory medications, or any prescribed therapy without guidance from the clinician who manages those medications.

What Does the Evidence Show and is it Safe?

Research is encouraging, especially for male and female pattern hair loss. Recent systematic reviews of randomized trials have reported improvements in hair density for many PRP-treated patients. PRP outcomes are not identical from one protocol or patient to another. Current evidence supports PRP as a promising, minimally invasive treatment not as a guaranteed cure for hair loss. PRP will not revive a dead or nonviable follicle. Hair follicles work slowly, so PRP does not produce an immediate cosmetic change. When treatment is successful, an early reduction in shedding may be noticed before improvements in density or thickness become visible. Changes are generally evaluated over several months rather than days or weeks. Because pattern hair loss is progressive, we may recommend an initial treatment series followed by periodic maintenance. The number and timing of sessions should be personalized. There is no single protocol proven to be best for every patient. Because PRP comes from the your own blood, the risk of an allergic reaction to the injected material is low. Temporary tenderness, pinpoint bleeding, swelling, bruising, headache, or scalp sensitivity can occur. Infection is  uncommon but possible with any injection procedure. Careful preparation, sterile technique, appropriate patient screening, and proper injection placement all matter.

The Most Important Step Is an Accurate Diagnosis

PRP is most useful when it is matched to the right diagnosis and realistic treatment goal. Hair thinning can result from pattern hair loss, autoimmune disease, inflammation, scarring, hormonal changes, nutritional deficiency, medications, illness, or several causes at once. PRP can provide valuable biological support to follicles that are weakened but still capable of producing hair.

For decades, the medical treatment of pattern hair loss has revolved largely around a small number of established medications. Minoxidil and finasteride have helped millions of patients preserve and, in some cases, improve their hair, while dutasteride is also used in certain patients. But hair-loss research is entering a particularly interesting period. Scientists are looking much deeper into the biology of the hair follicle, examining the molecular signals that regulate growth, the metabolism of follicular stem cells, the androgen receptor itself, and the mechanisms that allow a dormant follicle to potentially re-enter an active growth state. Several experimental medications are now progressing through clinical development, and some work very differently from today’s conventional treatments. None of this means that established treatments are becoming obsolete. But it does suggest that the future of hair restoration may give physicians more ways to target the biology responsible for hair loss.

Why Hair-Loss Research Is Changing

Androgenetic alopecia, commonly called male or female pattern hair loss, is not simply a condition in which hairs suddenly disappear. It is a progressive biological process. In genetically susceptible follicles, androgen signaling, particularly the effects of dihydrotestosterone, or DHT, contributes to progressive follicular miniaturization. A follicle that once produced a thick terminal hair gradually produces a finer, shorter and less visible hair. Traditional medications approach this process in different ways. Finasteride reduces the conversion of testosterone to DHT. Minoxidil acts through a different mechanism and helps promote a more favorable environment for hair growth. Researchers are now investigating entirely different points along this biological pathway. Instead of only asking, “How can we reduce DHT?”, researchers are asking questions such as: Can we block androgen activity directly within the scalp? Can we remove androgen receptors from follicular cells? Can we reactivate dormant follicular stem cells? Can we alter cellular metabolism to encourage a follicle to return to growth? Those questions are producing a new generation of potential hair-loss treatments.

PP405: Can Dormant Hair Follicles Be Reactivated?

One of the most closely watched experimental treatments is PP405. PP405 represents an interesting departure from traditional hair-loss medication because it is being developed around the biology and metabolism of hair follicle stem cells. Hair follicle stem cells can remain present even when a follicle is no longer producing a substantial visible hair. Researchers have discovered that the metabolic state of these cells appears to play an important role in determining whether they remain dormant or become active. PP405 is a topical investigational drug designed to influence this metabolic process and encourage dormant follicular stem cells to re-enter an active state. That concept is significant. Rather than simply attempting to slow further miniaturization, the objective is to investigate whether follicles that have become inactive can be biologically stimulated to produce terminal hair again. Early Phase 2 research has produced encouraging signals, and later-stage clinical development is planned. Researchers are now trying to determine whether these early findings can be reproduced in larger groups of men and women and sustained over longer periods. PP405 remains experimental, but its mechanism illustrates one of the most interesting directions in modern hair research: reactivating the follicle rather than simply protecting it from further loss.

Clascoterone: Blocking Androgen Signaling at the Follicle

Another major area of research involves blocking androgen signaling directly within the scalp. Clascoterone is a topical androgen-receptor inhibitor being studied for male pattern hair loss. Instead of reducing the body’s production of DHT, the concept is to interfere with the ability of androgens to activate their receptors locally within the skin. Think of DHT as a key and the androgen receptor as the lock. Finasteride attempts to reduce the amount of DHT, the number of keys. A topical androgen-receptor blocker takes a different approach: it attempts to prevent the key from successfully activating the lock within the targeted tissue. Large Phase 3 studies of topical Clascoterone have now been completed, and longer-term data have continued to show hair growth among patients remaining on treatment. The manufacturer is preparing regulatory submissions, including a planned U.S. application. If eventually approved for pattern hair loss, a topical androgen-receptor treatment could add an entirely different therapeutic strategy to the options available to patients.

Pyrilutamide: Another Approach to the Androgen Receptor

Pyrilutamide, also known as KX-826, is another investigational topical treatment designed to interfere with androgen-receptor signaling. The drug competes with androgens for the androgen receptor within the targeted tissue. In 2026, a large Phase 3 study in China involving more than 600 men reported a statistically significant increase in target-area non-vellus hair counts compared with placebo. That is an encouraging development, although regulatory approval in one country does not automatically translate into approval elsewhere, and additional regulatory and clinical work remains relevant to its future availability in North America. What makes pyrilutamide particularly interesting is the broader trend it represents. Researchers are increasingly investigating whether androgen signaling can be controlled locally within the scalp, potentially reducing the need for extensive systemic exposure.

GT20029: Instead of Blocking the Androgen Receptor, Can We Remove It?

GT20029 takes the androgen-receptor concept one step further. It belongs to an emerging class of drugs known as PROTACs-proteolysis-targeting chimeras. The science behind PROTAC technology is fascinating. Traditional receptor blockers attempt to occupy a receptor so another molecule cannot activate it. A PROTAC is designed to do something different: it recruits the cell’s own protein-disposal machinery and directs it toward a specific unwanted protein. In the case of GT20029, that target is the androgen receptor. Rather than simply blocking the receptor temporarily, the objective is to cause the receptor protein itself to be degraded within the targeted cells. As the number of available androgen receptors decreases, androgen signaling within the follicle could potentially decrease as well. A Phase 2 study in men with androgenetic alopecia reported increases in non-vellus hair counts with certain dosing regimens and generally good tolerability. Further clinical investigation is needed, but GT20029 demonstrates how sophisticated the next generation of hair-loss pharmacology is becoming.

ET-02: Targeting Follicular Stem-Cell Biology

Another investigational topical drug attracting attention is ET-02. Its developers are studying a different aspect of hair-follicle biology involving the mechanisms that regulate follicular stem-cell activity. The underlying idea again reflects an important change in how scientists think about hair loss. A miniaturized or poorly functioning follicle is not necessarily biologically empty. Cells involved in producing hair may still be present, but their normal signaling and activation mechanisms may have changed. ET-02 is being investigated as a way of influencing that biology. Early first-in-human research has reported increased hair growth over a relatively short treatment period, and a larger Phase 2 clinical program is expected to follow. These are still very early findings and need confirmation in much larger controlled trials. Nevertheless, ET-02 belongs to an increasingly important category of research focused on restoring follicular function rather than exclusively altering hormones.

Why Stem Cells Are Becoming So Important in Hair Research

One of the most fascinating discoveries in modern hair biology is that a follicle can contain stem cells even when it is no longer producing the thick hair it once did. Hair follicle stem cells normally participate in the repeated regeneration of the follicle during successive hair-growth cycles. The problem may therefore not always be the complete absence of these cells. In some forms of hair loss, part of the problem may involve the biological signals that tell those cells when to become active, how to differentiate and how to participate in creating a new growing hair. This is why researchers are investigating cellular metabolism, signaling pathways and the microenvironment surrounding the follicle. It also explains why the distinction between a dormant or miniaturized follicle and a permanently destroyed follicle is so important. A follicle that still contains viable biological machinery presents a very different therapeutic opportunity from one that has been permanently destroyed by scarring or other processes.

Beyond DHT: Hair Loss Is Becoming a Molecular Science

Perhaps the most exciting aspect of current research is the realization that there may never be one universal “hair-loss drug.” The follicle is a miniature organ influenced by hormones, genetics, cellular metabolism, immune signaling, vascular supply, growth factors and communication between multiple cell populations. Researchers are consequently investigating several different biological targets. Some experimental treatments attempt to block androgen receptors. Others attempt to degrade them. Others are investigating follicular stem cells, cellular energy metabolism and the molecular signals controlling the transition between resting and growing follicles. Other areas of research are exploring immune pathways and biologic therapies for specific forms of alopecia. The future may therefore involve increasingly personalized treatment based upon the biological reason a patient’s hair is being lost.

 What Does This Mean for Patients Today?

New research is exciting, but it is important to distinguish between a promising clinical trial and an approved treatment. Many drugs that perform well in early research never ultimately reach patients. Larger clinical trials may reveal that an effect is smaller than originally thought, that results are inconsistent, or that unexpected safety issues emerge. That is exactly why medications progress through multiple phases of clinical trials before regulatory approval. PP405, ET-02 and GT20029 remain investigational. Other therapies, including Clascoterone and pyrilutamide, are further along in development in certain markets, but their regulatory status varies by country. Patients should therefore be cautious about websites or clinics presenting experimental medications as though they are already established treatments. At the same time, there is legitimate reason for optimism. Hair-loss research is moving beyond a handful of mechanisms that have dominated treatment for decades.

The Future May Be Combination Hair Restoration

The future of hair restoration may not involve choosing one treatment over another. It may increasingly involve combining treatments that address different parts of the hair-loss process. One therapy might reduce androgen signaling. Another might support follicular growth. Regenerative treatments might influence the environment surrounding viable follicles. And when follicles have been permanently lost, FUE or FUT hair transplantation can redistribute healthy donor follicles into areas requiring restoration. The ability to approach hair loss from several biological directions may eventually allow physicians to create increasingly individualized treatment strategies.

Looking Ahead at De Haar Hair Restoration

At De Haar Hair Restoration, we believe advances in hair-loss research are important because better science leads to better questions—and ultimately to better treatment options. Dr. Bea Gerbrands’ approach begins with diagnosis. Before deciding how to treat hair loss, it is important to understand what type of hair loss is occurring, whether follicles are miniaturizing or being destroyed, whether an underlying medical or inflammatory condition is present, and what treatments are supported by evidence today. The next generation of hair-loss medications is particularly exciting because researchers are no longer looking at the follicle simply as a hair-producing structure. They are studying it at the molecular and cellular level. From androgen-receptor degradation to follicular stem-cell activation, the science is moving quickly. Some of today’s experimental treatments will undoubtedly change as research progresses, and not every candidate will ultimately become an approved medication. But the direction is encouraging.

There Isn’t a Perfect Age Only the Right Time

One of the most common questions people ask during a hair restoration consultation is, “Am I too young for a hair transplant?” Others wonder if they have waited too long. The answer may be surprising: there is no single “ideal” age for a hair transplant. While age is certainly one consideration, it is rarely the deciding factor. A successful hair transplant depends far more on the pattern and stability of your hair loss, the quality of your donor hair, your overall health, and your long-term goals. The best candidates are those whose treatment can be planned not only for today, but for the years and decades ahead.

Hair loss is often progressive. A person who has a small amount of thinning in their twenties may experience significantly more hair loss over the next 10 or 20 years. For this reason, experienced hair restoration surgeons look beyond the immediate concern and develop a treatment plan that is designed to continue looking natural as hair changes over time. The goal is not simply to restore hair but to to create a result that ages gracefully and remains in harmony with your facial features for years to come.

Does Age Really Matter?

Although many people assume there is a “minimum age” for hair transplantation, there is no universally accepted age at which someone becomes an ideal candidate. Some individuals may be appropriate candidates in their early twenties, while others may benefit from waiting several more years. Likewise, healthy patients in their sixties or seventies may still enjoy excellent results. Rather than focusing on your age, experienced surgeons evaluate several important factors: The pattern of your hair loss and whether it appears stable or is still rapidly progressing. The quality and density of your donor hair, usually taken from the back and sides of the scalp. Your family history, which may provide insight into how your hair loss could develop over time, Your overall health, including any medical conditions that could affect healing or hair growth and  Your expectations, ensuring they are realistic and aligned with what modern hair transplantation can achieve. read about who is an ideal candidate.

Conclusion

Every patient is different. Two people of the same age can have completely different patterns of hair loss and very different treatment recommendations. This is why an individualized consultation is far more valuable than relying on age alone. Ultimately, the right time for a hair transplant is when your surgeon can confidently design a restoration plan that not only addresses your current hair loss but also anticipates future changes, helping you achieve natural-looking results that stand the test of time. learn about early hair loss in men.